newsfilter
← Latest News
PR Newswire·

Orexo announces positive results from pivotal trial for its leading pharmaceutical pipeline asset OX124

UPPSALA, Sweden, Nov. 16, 2021 /PRNewswire/ -- Orexo AB (publ.), (STO:ORX) (OTCQX:ORXOY) today announces that the company has successfully completed the pivotal trial (OX124-002) for its lead pharmaceutical pipeline asset, OX124. The study met its prim